跳至主要内容
临床试验/CTRI/2024/06/068527
CTRI/2024/06/068527尚未招募4 期

Graft Rinse prior to reperfusion In LDLT, an RCT : GRIT Trial

Amrita Vishwa Vidyapeetham1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年7月15日最近更新:

试验速览

阶段
4 期
状态
尚未招募
入组人数
30
试验地点
1
主要终点
incidence of postreperfusion syndrome between

研究概览

简要总结

This  study is to compare the incidence of postreperfusion syndrome between the control group  (graft rinse with retrograde filling) and the intervention group (graft rinse with HETA starch solution) during liver transplantation to reduce the post-perfusion syndrome and improve  post-operative outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • All adult patients undergoing live donor liver transplantation.

排除标准

  • Patient refusing to consent Pediatric Transplants Patients refusing to consent trial.

结局指标

主要结局

incidence of postreperfusion syndrome between

时间窗: at 5 minutes post-reperfusion,

control group and intervention group

时间窗: at 5 minutes post-reperfusion,

次要结局

  • lengths of intensive(care stay & hospital stay, Early allograft Dysfunction,)

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Sudhindran S

Amrita Institute of Medical Sciences and Research Centre

研究点 (1)

Loading locations...

相似试验